Regen BioPharma, Inc.
RGBP
$0.026
$0.000.00%
OTC PK
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | 59.10K | 59.10K | 59.10K | 59.40K | 59.10K |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 59.10K | 59.10K | 59.10K | 59.40K | 59.10K |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | 59.10K | 59.10K | 59.10K | 59.40K | 59.10K |
SG&A Expenses | 99.80K | 172.40K | 120.40K | 112.20K | 134.50K |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 99.80K | 172.40K | 120.40K | 145.70K | 167.00K |
Operating Income | -40.80K | -113.30K | -61.40K | -86.40K | -108.00K |
Income Before Tax | -167.30K | -19.40K | -515.40K | -264.90K | -130.10K |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -167.30K | -19.40K | -515.40K | -264.90K | -130.10K |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -167.30K | -19.40K | -515.40K | -264.90K | -130.10K |
EBIT | -40.80K | -113.30K | -61.40K | -86.40K | -108.00K |
EBITDA | -- | -- | -- | -- | -- |
EPS Basic | -0.01 | 0.00 | -0.13 | -0.03 | -0.03 |
Normalized Basic EPS | 0.00 | 0.00 | -0.08 | -0.02 | -0.02 |
EPS Diluted | -0.01 | 0.00 | -0.13 | -0.03 | -0.03 |
Normalized Diluted EPS | 0.00 | 0.00 | -0.08 | -0.02 | -0.02 |
Average Basic Shares Outstanding | 23.75M | 21.55M | 4.11M | 9.04M | 4.21M |
Average Diluted Shares Outstanding | 23.75M | 21.55M | 4.11M | 9.04M | 4.21M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |